Strategic update on the progress and development of Molecure's key clinical projects in 2024
Molecure achieved key milestones in the development of its innovative therapies in 2024 and plans to accelerate research and development in its ...
Anocca Announces Authorisation of Clinical Trial Application to Start First In-Human Trial ...
CTA approval marks Anocca’s transition to a clinical-stage companyFirst-in-human VIDAR-1 trial begins with the deployment of ANOC-001 in Advanced ...